Shree Ganesh Rem

26
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE414Y01015
  • NSEID:
  • BSEID: 540737
INR
449.00
-5.85 (-1.29%)
BSENSE

Dec 05

BSE+NSE Vol: 4.35 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Shree Ganesh Rem Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'20
Mar'19
No of Months
12
12
12
12
Profit Before Tax
31.00
38.00
10.00
6.00
Adjustment
11.00
5.00
0.00
2.00
Changes In working Capital
-1.00
-5.00
-5.00
-13.00
Cash Flow after changes in Working Capital
40.00
38.00
4.00
-5.00
Cash Flow from Operating Activities
30.00
30.00
4.00
-5.00
Cash Flow from Investing Activities
-35.00
-33.00
-2.00
0.00
Cash Flow from Financing Activities
-1.00
9.00
0.00
0.00
Net Cash Inflow / Outflow
-5.00
7.00
1.00
-5.00
Opening Cash & Cash Equivalents
15.00
8.00
1.00
6.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
9.00
15.00
2.00
0.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Shree Ganesh Rem
Markets Mojo
Figures in Cr
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
31.27
34.47
-3.00
-9.28%
Adjustment
11.18
1.16
10.00
863.79%
Changes In working Capital
-1.73
-9.63
8.00
82.04%
Cash Flow after changes in Working Capital
40.72
26.01
14.00
56.56%
Cash Flow from Operating Activities
30.66
17.54
13.00
74.80%
Cash Flow from Investing Activities
-35.48
-39.95
4.00
11.19%
Cash Flow from Financing Activities
-1.09
13.24
-14.00
-108.23%
Net Cash Inflow / Outflow
-5.91
-9.16
4.00
35.48%
Opening Cash & Cash Equivalents
15.85
18.96
-3.00
-16.40%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
9.95
9.8
0.00
1.53%
Cash Flow - Snapshot (Consolidated) - Mar'25
stock-summary

YoY Growth in year ended Mar 2025 is 0.69% vs NA in Mar 2024

Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
30.66
30.45
0.69%